2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, connective tissue disorder, hematologic disorder, hemolytic anemia, immune system disorder, systemic lupus erythematosusRecruitingEarly phase 12026-06-05NCT07629596
A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)primary central nervous system lymphomaActive, not recruitingPhase 1 / Phase 22025-09-26NCT05485753